NCT03508557

Brief Summary

This study evaluates the use of advance care planning conversation tools with patients attending their family doctor's office. Patients complete tools about their values and wishes, and a health care provider uses a structured discussion tool to talk about the patient's health condition and future wishes. The patient's family member/substitute decision-maker is encouraged to attend and be part of the discussions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2018

Typical duration for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 16, 2018

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 25, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2018

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2020

Completed
Last Updated

January 19, 2022

Status Verified

January 1, 2022

Enrollment Period

2.3 years

First QC Date

April 16, 2018

Last Update Submit

January 17, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Advance care planning engagement

    Survey measuring domains of engagement in advance care planning

    12 weeks

Secondary Outcomes (3)

  • Advance care planning engagement-substitute decision maker

    12 weeks

  • Patient experience

    12 weeks

  • Patient perceived impact on health care

    6-9 months

Other Outcomes (2)

  • Clinician experience of intervention

    6 months

  • Clinician confidence having advance care planning conversations

    6 months

Study Arms (1)

Advance care planning tools

EXPERIMENTAL

Advance care planning education and structured conversation using tools

Behavioral: Advance care planning tools

Interventions

Structured conversations between patients/substitute decision-maker and clinician based on education about advance care planning using locally relevant booklet/website, values clarification tool for patient engagement, clinician use of the Serious Illness Conversation Guide

Advance care planning tools

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 60 or older
  • chronic condition that may reduce life expectancy as per physician's clinical judgement
  • able to communicate verbally in English and read English

You may not qualify if:

  • unable to communicate verbally in English
  • unable to read English
  • cognitively unable to give informed consent (e.g. memory problems) as judged by referring physician or research assistant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Sunridge Family Medicine Teaching Centre

Calgary, Alberta, T1Y 5S3, Canada

Location

Safa Medical Clinic

Langley, British Columbia, Canada

Location

New Westminster Family Practice

Vancouver, British Columbia, V3L 3C2, Canada

Location

Vancouver General Hospital Gordon and Leslie Diamond Health Care Centre

Vancouver, British Columbia, Canada

Location

Related Publications (1)

  • Stevens J, Elston D, Tan A, Barwich D, Carter RZ, Cochrane D, Frenette N, Howard M. Clinicians' experiences implementing an advance care planning pathway in two Canadian provinces: a qualitative study. BMC Prim Care. 2024 Jun 15;25(1):217. doi: 10.1186/s12875-024-02468-4.

MeSH Terms

Conditions

Chronic Disease

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Michelle Howard, PhD

    McMaster University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: Single group before-after
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 16, 2018

First Posted

April 25, 2018

Study Start

June 1, 2018

Primary Completion

September 30, 2020

Study Completion

October 30, 2020

Last Updated

January 19, 2022

Record last verified: 2022-01

Locations